Snowden Capital Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,565
Closed -$221K 1168
2023
Q2
$221K Buy
1,565
+36
+2% +$5.77K 0.01% 1068
2023
Q1
$257K Sell
1,529
-83
-5% -$14.8K 0.01% 995
2022
Q4
$273K Sell
1,612
-12,668
-89% -$2.3M 0.01% 953
2022
Q3
$2.67M Buy
14,280
+12,667
+785% +$2.67M 0.12% 207
2022
Q2
$261K Buy
1,613
+146
+10% +$23.1K 0.01% 927
2022
Q1
$275K Buy
1,467
+1,371
+1,428% +$260K 0.01% 865
2021
Q4
$25K Buy
+96
New +$25.9K ﹤0.01% 1257
2021
Q2
Sell
-30,660
Closed -$5.96M 895
2021
Q1
$5.96M Buy
30,660
+2,285
+8% +$468K 0.34% 71
2020
Q4
$5.44M Buy
28,375
+943
+3% +$172K 0.36% 76
2020
Q3
$4.05M Buy
27,432
+13,060
+91% +$1.87M 0.32% 90
2020
Q2
$1.78M Buy
+14,372
New +$1.69M 0.15% 194

Other funds holding RGEN

Snowden Capital Advisors's RGEN Position: Q3 2023 in Review

Snowden Capital Advisors sold out of Repligen (RGEN) in Q3 2023, closing a stake of 1,565 shares — an estimated $221K sold.

Snowden Capital Advisors first reported a position in RGEN in Q2 2020 and held it in 11 quarters. The position peaked at $5.96M in Q1 2021. 439 funds tracked by Wall St. Rank hold RGEN as of Q3 2023.

  • Snowden Capital Advisors reported no remaining Repligen position as of Q3 2023 after selling out during the quarter.
  • Snowden Capital Advisors sold 1,565 Repligen shares in Q3 2023, an estimated $221K.
  • Snowden Capital Advisors first reported a position in Repligen in Q2 2020 and held it in 11 quarters.
  • Snowden Capital Advisors's Repligen position peaked at $5.96M in Q1 2021.
  • 439 funds tracked by Wall St. Rank held Repligen as of Q3 2023.

Based on Snowden Capital Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.